» Authors » K Thom

K Thom

Explore the profile of K Thom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 137
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stromer W, Messerer B, Crevenna R, Hemberger S, Jauk B, Schwarz R, et al.
Schmerz . 2018 Sep; 32(6):404-418. PMID: 30191308
Background: Children and adolescents with severe hemophilia commonly suffer from acute and chronic pain as a consequence of hemophilia-related bleeding. Intervention-related pain also plays a major role. Despite its high...
2.
Thom K, Hanslik A, Russell J, Williams S, Sivaprakasam P, Allen U, et al.
Int J Cardiol . 2017 Nov; 252:74-79. PMID: 29126655
Background: Pediatric infective endocarditis (IE) has been associated with high morbidity and mortality, mostly related to thromboembolic complications (TEC). The objective of our study was to describe the experience in...
3.
Hanslik A, Kitzmuller E, Tran U, Thom K, Karapetian H, Prutsch N, et al.
J Thromb Haemost . 2016 Oct; 15(1):38-46. PMID: 27736032
Summary: Background Unfractionated heparin (UFH) is used for the prophylaxis and treatment of thrombosis in children. Laboratory monitoring of UFH is needed to prevent over-anticoagulation or under-anticoagulation. Objectives To investigate...
4.
Thom K, Male C, Mannhalter C, Quehenberger P, Mlczoch E, Luckner D, et al.
J Thromb Haemost . 2014 Aug; 12(10):1610-5. PMID: 25131188
Background And Objective: Central venous lines (CVLs) are the major exogenous risk factor for deep venous thrombosis (DVT) in children. The study objective was to assess whether endogenous prothrombotic conditions...
5.
Hanslik A, Kitzmuller E, Thom K, Haumer M, Mlekusch W, Salzer-Muhar U, et al.
J Thromb Haemost . 2011 Oct; 9(12):2353-60. PMID: 22008390
Background: During cardiac catheterization (CC) in children, unfractionated heparin (UFH) is used for primary prophylaxis of thrombotic events (TE). However, the optimal UFH dose to minimize TE and bleeding in...
6.
Thom K, Cleland A, Salakova M, Candotti D, Petrik J
Transfus Med . 2010 Oct; 21(1):42-50. PMID: 20880324
Objectives: To establish prevalence and phylogenetic relationship of SEN virus (SENV) D and H in blood donors from Scotland, Czech Republic and Ghana. Aim: To compare the data between three...
7.
Ay C, Thom K, Abu-Hamdeh F, Horvath B, Quehenberger P, Male C, et al.
Haemophilia . 2009 Sep; 16(1):111-7. PMID: 19758307
Factor VIII (FVIII) levels show a considerable variability in female carriers of haemophilia A. Presently, the reasons for this are poorly understood. The aim of the study was to elucidate...
8.
Thom K, Bontikous S, Engelhardt M, During T, Schulte M
Unfallchirurg . 2009 Jun; 112(7):656-60. PMID: 19543872
Chondrosarcoma is the second most frequent mesenchymal malignant tumour of the bone. Classification of this kind of tumour is made by clinical, radiological und pathological means. A case of an...
9.
Thom K, Male C, Falger J, Pabinger I
Hamostaseologie . 2009 May; 29(2):149-50. PMID: 19404512
The most serious complication of haemophilia A is development of a high-titre factor VIII (FVIII) inhibitor which renders the patient unresponsive to FVIII replacement. Bleeding complications can only be controlled...
10.
Hudson J, King N, Cornelius A, Bigwood T, Thom K, Monson S
Int J Food Microbiol . 2008 Jan; 123(1-2):25-31. PMID: 18206260
The methods available for the isolation of Yersinia enterocolitica from foods are generally considered to be less than optimal, and methods for estimation of numbers are lacking. Such methods are...